semaglutide and cardiovascular disease The weight-loss drug Wegovy lowered heart attack risk in a large trial New Science Suggests Semaglutide Improves

Does GLP-1 give you heartburn

CMS will offer eligible Medicare beneficiaries GLP-1 medications for $50 per month starting July 2026

Lot 6040411 COA issued 07/06/2026 Independent lab-verified data for potency, heavy metals & microbiology

Clinical trials (ten studies, 419 participants) using doses from 400 mg to 10 g over 21 days to 20 months show consistent reductions in fasting glucose, post-meal glucose, and HbA1c. In diabetic animal studies, gymnema increased proglucagon gene expression (a precursor for GLP-1) and insulin gene activity, suggesting it may help amplify endogenous GLP-1 production

eMed Population Health has been named a Novocare Recognized Care Provider by Novo Nordisk, enabling access to the newly FDA-approved Wegovy pillthe first and only oral GLP-1 approved for chronic weight management in adults